Clinical Trial Update: Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the impact of liraglutide on cardiovascular endpoints in adults with type 2 diabetes; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Diastolic Dysfunction
• Metabolic Syndrome
• Nonalcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Diabetes Mellitus Type 2, Metabolic Syndrome | Phase 4 | Status: COMPLETED